Bruker, Beckman Coulter, Invitrogen, PerkinElmer, Invitrogen, Luminex, ABI, NIH, Lawrence Berkeley National Laboratory, Russian Health Ministry, Thermo, Compugen, Sigma-Aldrich, Agilent

Bruker Posts 90-Percent Jump in Q1 Profit Despite Slight Revenue Slip

Bruker BioSciences this week posted a slight drop in first quarter revenues even though net income swelled by nearly 90 percent.

For the quarter ended March 31, revenues were $74.4 million, down less than 1 percent from the $74.9 million the company earned in the first quarter of 2005.

Bruker said that it spent $10.3 million on R&D in the first quarter, compared to $11 million in the comparable period last year.